A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy

NCT06816251 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG: HRS-1893
DRUG: HRS-1893 placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.